HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Long-term treatment of senile macular degeneration with Cosaldon A+E].

Abstract
During the early phase of senile degeneration of the macula treatment with Cosaldon A+E offers real changes of improvement. In the later phases long-term Cosaldon therapy can bring about an appreciable improvement when other vasoactive substances are administered at intervals. The addition of the vitamins A and E improves the efficacy of Cosaldon. Results in 157 patients are supported by statistics.
AuthorsH Stark
JournalKlinische Monatsblatter fur Augenheilkunde (Klin Monbl Augenheilkd) Vol. 187 Issue 4 Pg. 296-302 (Oct 1985) ISSN: 0023-2165 [Print] Germany
Vernacular TitleLangzeitbehandlung der senilen Makuladegeneration mit Cosaldon A+E.
PMID3934458 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Drug Combinations
  • Nicotinic Acids
  • nicotinic acid, pentifylline drug combination
  • Vitamin A
  • Vitamin E
  • vitamin A, pentifyllin, nicotinic acid, and vitamin E combination
  • Theobromine
Topics
  • Adult
  • Aged
  • Drug Combinations (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Long-Term Care
  • Macular Degeneration (drug therapy)
  • Male
  • Middle Aged
  • Nicotinic Acids (therapeutic use)
  • Theobromine (analogs & derivatives, therapeutic use)
  • Visual Acuity (drug effects)
  • Vitamin A (therapeutic use)
  • Vitamin E (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: